{"id":14741,"date":"2016-10-04T09:04:48","date_gmt":"2016-10-04T07:04:48","guid":{"rendered":"http:\/\/cms.munich-startup.net\/?p=14741"},"modified":"2016-10-04T17:45:17","modified_gmt":"2016-10-04T15:45:17","slug":"immunic-receives-175-million-euros-in-financing","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/14741\/immunic-receives-175-million-euros-in-financing\/","title":{"rendered":"Immunic receives 17.5 million euros in financing"},"content":{"rendered":"<div class=\"entry-content\"><p><strong>Immunic AG, a young, privately held biotech company in Planegg-Martinsried near Munich, has announced the successful completion of its first financing round (Series A) with a total amount of 17.5 million euros.<\/strong><\/p>\n<p>The financing round was led by co-lead investors Life Sciences Partners V Co\u00f6peratief UA (LSP, Netherlands) and LifeCare Partners (LCP, Switzerland). Other investors include Bayern Kapital (Landshut), High-Tech Gr\u00fcnderfonds (HTGF, Bonn), and private investors. Immunic, based in the Innovation and Startup Center for Biotechnology (<a href=\"http:\/\/www.izb-online.de\/de\/\" target=\"_blank\"><strong>IZB<\/strong><\/a>) in Martinsried, was founded in April 2016 with the concept of developing promising drug candidates up to the first proof of efficacy in patients (the so-called\u00a0 <em>clinical proof of concept<\/em>) to develop.<\/p>\n<p>The focus is on <a href=\"http:\/\/www.immunic.de\/\" target=\"_blank\"><strong>Immunic<\/strong><\/a> on immunomodulatory active ingredients that can be taken as tablets. These are intended to treat diseases with an immunological or autoimmune background. Such diseases include chronic inflammatory bowel disease (IBD) or psoriasis.<\/p>\n<p><strong>Dr. Manfred Gr\u00f6ppel<\/strong>, one of the Immunic founders and Chief Operating Officer:<\/p>\n<blockquote><p>&quot;The completion of this financing round is a validation for Immunic&#039;s founding team. We are very pleased to have the support of such experienced biotech investors. Both their financial commitment and their experience in the biotech industry will help us accelerate our development activities.&quot;<\/p><\/blockquote>\n<p><strong> Dr. Andreas M\u00fchler<\/strong>, also founder and Chief Medical Officer at Immunic, adds:<\/p>\n<blockquote><p>\u201cThe funding will enable us to develop innovative and effective, yet convenient, oral therapies for patients suffering from serious diseases involving the immune system.\u201d<\/p><\/blockquote>\n<h3>Aigner: \u201cThe entire business location benefits from this\u201d<\/h3>\n<blockquote><p>&quot;Innovative therapies are still urgently needed in the field of immunological and autoimmune diseases. Above all, therapies that can be administered safely and easily in tablet form are sought. Tablets are preferred by both patients and healthcare systems over intravenous administration,&quot;<\/p><\/blockquote>\n<p>explains Dr. J\u00f6rg Neermann, partner at LSP and chairman of the supervisory board of Immunic. <strong>Bavaria&#039;s Minister of Economic Affairs Ilse Aigner<\/strong> says:<\/p>\n<blockquote><p>&quot;I&#039;m pleased that the financing round was completed thanks in part to a contribution from the Bavarian Growth Fund. For us, Immunic, as with other startups, is about creating the best possible conditions for the development and implementation of innovative ideas. That&#039;s the fundamental idea of the Growth Fund. Innovations develop into products and companies, and the jobs of the future are created. The entire business location benefits from this.&quot;<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Immunic AG, a young, privately held biotech company based in Planegg-Martinsried near Munich, has announced the successful completion of its first financing round (Series A) with a total of \u20ac17.5 million. The financing round was led by co-lead investors Life Sciences Partners V Co\u00f6peratief UA (LSP, Netherlands) and LifeCare Partners (LCP, Switzerland). More...<\/p>","protected":false},"author":3,"featured_media":14842,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1,5635],"tags":[371,52,1499],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Immunic erh\u00e4lt 17,5 Millionen Euro Finanzierung - Munich Startup<\/title>\n<meta name=\"description\" content=\"Die Immunic AG hat den erfolgreichen Abschluss ihrer ersten Finanzierungsrunde (Serie A) mit einer Gesamtsumme von 17,5 Millionen Euro bekanntgegeben.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/14741\/immunic-receives-175-million-euros-in-financing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunic erh\u00e4lt 17,5 Millionen Euro Finanzierung - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Die Immunic AG hat den erfolgreichen Abschluss ihrer ersten Finanzierungsrunde (Serie A) mit einer Gesamtsumme von 17,5 Millionen Euro bekanntgegeben.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/14741\/immunic-receives-175-million-euros-in-financing\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/profile.php?id=100009572160192\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-04T07:04:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-10-04T15:45:17+00:00\" \/>\n<meta name=\"author\" content=\"Florian Deglmann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FlorianDeglmann\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Florian Deglmann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/\",\"url\":\"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/\",\"name\":\"Immunic erh\u00e4lt 17,5 Millionen Euro Finanzierung - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/09\/DNA.jpg\",\"datePublished\":\"2016-10-04T07:04:48+00:00\",\"dateModified\":\"2016-10-04T15:45:17+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251\"},\"description\":\"Die Immunic AG hat den erfolgreichen Abschluss ihrer ersten Finanzierungsrunde (Serie A) mit einer Gesamtsumme von 17,5 Millionen Euro bekanntgegeben.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/09\/DNA.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/09\/DNA.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Immunic\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunic erh\u00e4lt 17,5 Millionen Euro Finanzierung\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251\",\"name\":\"Florian Deglmann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g\",\"caption\":\"Florian Deglmann\"},\"description\":\"Der Exil-N\u00fcrnberger erforschte bis April 2019 als Redakteur die M\u00fcnchner Startup-Szene.\",\"sameAs\":[\"http:\/\/cms.munich-startup.net\",\"https:\/\/www.facebook.com\/profile.php?id=100009572160192\",\"https:\/\/x.com\/FlorianDeglmann\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/deglmann\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2016\/09\/DNA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunic receives 17.5 million euros in financing - Munich Startup","description":"Immunic AG has announced the successful completion of its first financing round (Series A) with a total amount of 17.5 million euros.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/14741\/immunic-receives-175-million-euros-in-financing\/","og_locale":"en_US","og_type":"article","og_title":"Immunic erh\u00e4lt 17,5 Millionen Euro Finanzierung - Munich Startup","og_description":"Die Immunic AG hat den erfolgreichen Abschluss ihrer ersten Finanzierungsrunde (Serie A) mit einer Gesamtsumme von 17,5 Millionen Euro bekanntgegeben.","og_url":"https:\/\/cms.munich-startup.net\/en\/14741\/immunic-receives-175-million-euros-in-financing\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_author":"https:\/\/www.facebook.com\/profile.php?id=100009572160192","article_published_time":"2016-10-04T07:04:48+00:00","article_modified_time":"2016-10-04T15:45:17+00:00","author":"Florian Deglmann","twitter_card":"summary_large_image","twitter_creator":"@FlorianDeglmann","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Florian Deglmann","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/","url":"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/","name":"Immunic receives 17.5 million euros in financing - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/09\/DNA.jpg","datePublished":"2016-10-04T07:04:48+00:00","dateModified":"2016-10-04T15:45:17+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251"},"description":"Immunic AG has announced the successful completion of its first financing round (Series A) with a total amount of 17.5 million euros.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/09\/DNA.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/09\/DNA.jpg","width":1280,"height":720,"caption":"Immunic"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/14741\/immunic-erhaelt-175-millionen-euro-finanzierung\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Immunic erh\u00e4lt 17,5 Millionen Euro Finanzierung"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251","name":"Florian Deglmann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g","caption":"Florian Deglmann"},"description":"The exiled Nuremberg resident researched the Munich startup scene as an editor until April 2019.","sameAs":["http:\/\/cms.munich-startup.net","https:\/\/www.facebook.com\/profile.php?id=100009572160192","https:\/\/x.com\/FlorianDeglmann"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/deglmann\/"}]},"og_image":[{"width":1280,"height":720,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/09\/DNA.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1515752782:28","_edit_last":"3","_yoast_wpseo_focuskw":"Immunic","_yoast_wpseo_metadesc":"Die Immunic AG hat den erfolgreichen Abschluss ihrer ersten Finanzierungsrunde (Serie A) mit einer Gesamtsumme von 17,5 Millionen Euro bekanntgegeben.","_yoast_wpseo_linkdex":"85","_thumbnail_id":"14842","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"Immunic","_yoast_wpseo_content_score":"","ms_image_format":"","_ms_image_format":"","ms_dachzeile":"","_ms_dachzeile":"","ms_bump_post_date":"","_ms_bump_post_date":"","guest_author_name":"","_guest_author_name":"","guest_author_image":"","_guest_author_image":"","guest_author_description":"","_guest_author_description":"","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"immunic-schliesst-erfolgreich-erste-finanzierungsrunde-ueber-175-millionen-euro-ab","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/14741"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=14741"}],"version-history":[{"count":0,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/14741\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/14842"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=14741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=14741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=14741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}